COVID-19 TIMELINE – chronological

COVID-19 has made it clear that public health is essential to economic recovery.
The notion that we must choose between them is ridiculous – and has had deadly consequences.

The timeline plots the history of COVID-19, from the first reported case to current events,
which are kept regularly updated.

It can be viewed chronologically, as things happened, or by most recent events first.
Here you can find more a detailed introduction and a guide to abbreviations.

This timeline will be updated approximately weekly throughout 2021.
Please check back for the latest developments.

11 January 2020

41 people in Wuhan City receive a preliminary diagnosis of novel coronavirus; seven cases are severe and one person with serious underlying medical conditions died. The Chinese government reports no clear evidence that the virus is easily transmitted from person-to-person. Source 

13 January 2020

The first confirmed case of illness from the novel coronavirus outside of China is reported in Thailand in a traveler from Wuhan who was hospitalized on 8 January. Source

14 January 2020

WHO notes the possibility of person-to-person transmission of the novel coronavirus, and  the potential for a wider outbreak. 

20 January 2020

• First US case of novel coronavirus reported in Washington State, in a man who had visited Wuhan.
• China declares that the outbreak is an emergency. Source

21 January 2020

WHO regional representatives visit Wuhan.

22 January 2020

• In a press statement, WHO reports that Chinese epidemiological research and roll-out of testing suggest person-to-person transmission of the novel coronavirus. Source
• WHO Director General convenes an emergency committee to assess whether the novel coronavirus is a public health emergency of international concern. The committee did not reach consensus based on available evidence and asked to reconsider the matter within 10 days after they had more information.

23 January 2020

• Moderna, a Cambridge, Massachusetts-based biotechnology company, announces that it has been awarded funding to develop a messenger RNA (mRNA)-based coronavirus vaccine. The vaccine was designed in collaboration with The Vaccine Research Center (VRC) of the National Institute of Allergy and Infectious Diseases (NIAID), will be developed in partnership with the Coalition for Epidemic Preparedness Innovations  (CEPI).  As part of the partnership, NIAID will conduct a Phase I clinical study in the U.S. Source
• Inovio receives a grant of up to $9 million from CEPI to develop its DNA COVID-19 vaccine candidate, INO-4800, which was designed three hours after the company got the genetic sequence of SARS-CoV-2. Source

24 January 2020

First report of person-to-person novel coronavirus transmission reported among a family of 6. Source 

30 January 2020

Emergency committee reconvenes; advises that the outbreak is a public health emergency of international concern and the Director-General announces it. The WHO risk assessment for China is very high and considered high at regional- and global levels. Globally, 7,818 confirmed cases of illness from the novel coronavirus have been reported across 19 countries. In order of cases: China (7,736); Thailand (14); Japan (11); Singapore (10); Australia (7); Malaysia (7); France (5); USA (5); Germany (4); Republic of Korea (4); United Arab Emirates (4); Canada (3); Viet Nam (2); Cambodia (1); Finland (1); India (1); Nepal (1); Philippines (1); and Sri Lanka (1). Source

2 February 2020

First COVID-19 death reported outside of China – in the Philippines. Source